Ocrevus Zunovo

Product NDC
50242-554
11-digit product format
502420554
Labeler code
50242
Product ID
50242-554_30b58964-86ef-483b-9a38-7f9fec14647c
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
ocrelizumab and hyaluronidase
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Labeler
Genentech, Inc.
Application
BLA761371
Marketing category
BLA
Marketing start
2024-09-13
Substance
HYALURONIDASE (HUMAN RECOMBINANT); OCRELIZUMAB
Active strength
23000; 920 U/23mL; mg/23mL
Pharmacologic classes
Antibodies, Monoclonal [CS], Antibodies, Monoclonal, Humanized [CS], CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC], Endoglycosidase [EPC], Glycoside Hydrolases [CS]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Ocrevus Zunovo
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
HYALURONIDASE (HUMAN RECOMBINANT)23000 U/23mL
OCRELIZUMAB920 mg/23mL

Harmonized Identifiers#

Field, Values table
FieldValues
Unii743QUY4VD8, A10SJL62JY
Rxcui2693458, 2693465

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
fba5a780-b52d-4964-b662-1526b044aec4Product name120260127
64196b0b-840e-435b-8afa-0b0e9d9cea99Product name120251024
4b151d8d-9b47-43df-bccb-6abc1c4e7194Product name120250331
d745a796-f789-46a3-afa3-79dead22a863Product name120250331
00bb4496-246c-4f2c-910a-2b2783035958Product name120231025
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
bd11614e-4776-4a92-aaca-2bcbb5f710edProduct name120210115
0c6eff6a-9a1e-468b-b9ca-6bc864c2e8cbProduct name120200925
6d78c268-2e9d-bd45-9f2d-965fd0e582caProduct name220200323
b914e981-d6dc-4748-bd51-accd6b85b817Product name120190618
48747306-602a-42cc-957b-5b0c69158eeeProduct name120180604
4597a7a9-59c8-4eb4-b516-4f26fa3dfe4bProduct name120170804
0370057a-6e63-432c-842f-2aeb7aad1b53Product name120170613
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508
db5ebcdb-b6ae-21cd-4dc5-76cd84b5578bProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50242-554-01Ocrevus Zunovo1 in 1 CARTONINJECTION, SOLUTION19
50242-554-01Ocrevus Zunovo23 mL in 1 VIAL, SINGLE-USEINJECTION, SOLUTION239
50242-554-86Ocrevus Zunovo23 mL in 1 VIAL, SINGLE-USEINJECTION, SOLUTION239
50242-554-86Ocrevus Zunovo1 in 1 CARTONINJECTION, SOLUTION19

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50242-554-01ML - Milliliter50242-554d48b7c8f-3643-4419-aff0-0ffa7d699b5912024-10-04

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50242-554OCREVUS ZUNOVO (OCRELIZUMAB AND HYALURONIDASE) INJECTION, SOLUTION [GENENTECH, INC.]5Current NDC, 4 package rows20241127_b216af61-99d0-42a3-afc2-b5bf86df1ec0.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2693458ocrelizumab-ocsq 920 MG / hyaluronidase-ocsq 23,000 UNT in 23 ML InjectionPSNb216af61-99d0-42a3-afc2-b5bf86df1ec09
2693465Ocrevus Zunovo 920 MG / 23,000 UNT in 23 ML InjectionPSNb216af61-99d0-42a3-afc2-b5bf86df1ec09
269346523 ML hyaluronidase-ocsq 1000 UNT/ML / ocrelizumab-ocsq 40 MG/ML Injection [Ocrevus Zunovo]SBDb216af61-99d0-42a3-afc2-b5bf86df1ec09
269345823 ML hyaluronidase-ocsq 1000 UNT/ML / ocrelizumab-ocsq 40 MG/ML InjectionSCDb216af61-99d0-42a3-afc2-b5bf86df1ec09
2693458ocrelizumab-hyaluronidase-ocsq 920 MG / 23,000 UNT per 23 ML InjectionSYb216af61-99d0-42a3-afc2-b5bf86df1ec09
2693458ocrelizumab-ocsq 920 MG / hyaluronidase-ocsq 23,000 UNT per 23 ML InjectionSYb216af61-99d0-42a3-afc2-b5bf86df1ec09
2693465Ocrevus Zunovo (ocrelizumab-hyaluronidase-ocsq 920 MG / 23,000 UNT) per 23 ML InjectionSYb216af61-99d0-42a3-afc2-b5bf86df1ec09

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
50242-554-01502420554011 VIAL, SINGLE-USE in 1 CARTON (50242-554-01) / 23 mL in 1 VIAL, SINGLE-USE2024-09-13NoNoCurrent
50242-554-86502420554861 VIAL, SINGLE-USE in 1 CARTON (50242-554-86) / 23 mL in 1 VIAL, SINGLE-USE2024-09-13YesNoCurrent